TD Cowen Reiterates Hold Rating on Genmab A/S (GMAB)

October 11, 2024 8:46 AM EDT Send to a Friend
TD Cowen analyst Yaron Werber reiterated a Hold rating and $30.00 price target on Genmab A/S (NASDAQ: GMAB).The analyst commented ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login